Accounting for mortality as competing risk, the Afib burden trended numerically in favor of the GLP-1 RA group (HR 0.85, 95% ...

In this video at Obesity Medicine 2025, Harold E. Bays, MD, FOMA, FTOS, FACC, FASPC, FNLA, discusses highlights from his talk ...

Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.

The weekly shot that's transforming weight loss journeys. Discover how Zepbound is reshaping obesity treatment and offering ...

The Department of Health and Human Services announced this week that it would work to remove some artificial dyes from the ...

Dr. Makeda Dawkins discusses liver disease risks for African Americans, debunks detox myths, and shares prevention strategies ...

Hegseth shared a report from the Military Times on a study from the American Security Project, which found that over ...

Every 2 years, researchers from the American Cancer Society (ACS) publish a comprehensive report using data from multiple ...

I do believe it will help me live a healthier and happier life overall,” said one Petaluma resident who lost 119 pounds after ...

Comprehensive obesity care can treat a multitude of conditions, but it requires a “holistic recipe” of ingredients ranging from clinical education to effective interventions and reimbursement, a ...

Obesity is a chronic disease influenced by genetics, hormones, and metabolism, not merely overeating. Disruptions in leptin and ghrelin signaling, along with metabolic adaptation, contribute to weight ...

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...